These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
455 related articles for article (PubMed ID: 18355177)
1. Increased number of CD25 FoxP3 regulatory T cells in oral squamous cell carcinomas detected by chromogenic immunohistochemical double staining. Schwarz S; Butz M; Morsczeck C; Reichert TE; Driemel O J Oral Pathol Med; 2008 Sep; 37(8):485-9. PubMed ID: 18355177 [TBL] [Abstract][Full Text] [Related]
2. Tumor-infiltrating lymphocytes, particularly the balance between CD8(+) T cells and CCR4(+) regulatory T cells, affect the survival of patients with oral squamous cell carcinoma. Watanabe Y; Katou F; Ohtani H; Nakayama T; Yoshie O; Hashimoto K Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May; 109(5):744-52. PubMed ID: 20303300 [TBL] [Abstract][Full Text] [Related]
3. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208 [TBL] [Abstract][Full Text] [Related]
4. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation. Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134 [TBL] [Abstract][Full Text] [Related]
5. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer. Kiniwa Y; Miyahara Y; Wang HY; Peng W; Peng G; Wheeler TM; Thompson TC; Old LJ; Wang RF Clin Cancer Res; 2007 Dec; 13(23):6947-58. PubMed ID: 18056169 [TBL] [Abstract][Full Text] [Related]
6. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue. Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917 [TBL] [Abstract][Full Text] [Related]
7. Tumour infiltrating CD25+ FoxP3+ regulatory T cells (Tregs) relate to tumour grade and stromal inflammation in oral squamous cell carcinoma. Al-Qahtani D; Anil S; Rajendran R J Oral Pathol Med; 2011 Sep; 40(8):636-42. PubMed ID: 21352381 [TBL] [Abstract][Full Text] [Related]
8. Absence of amplification of CD4+CD25(high) regulatory T cells during in vitro expansion of tumor-infiltrating lymphocytes in melanoma patients. Knol AC; Lemaître F; Pandolfino MC; Volteau C; Quéreux G; Saiagh S; Khammari A; Viguier M; Dréno B Exp Dermatol; 2008 May; 17(5):436-45. PubMed ID: 18312383 [TBL] [Abstract][Full Text] [Related]
9. FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV-1 infection. Ndhlovu LC; Loo CP; Spotts G; Nixon DF; Hecht FM J Leukoc Biol; 2008 Feb; 83(2):254-62. PubMed ID: 17982112 [TBL] [Abstract][Full Text] [Related]
10. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells. Aarts-Riemens T; Emmelot ME; Verdonck LF; Mutis T Eur J Immunol; 2008 May; 38(5):1381-90. PubMed ID: 18412171 [TBL] [Abstract][Full Text] [Related]
11. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression. Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062 [TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human. Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers. Badoual C; Hans S; Rodriguez J; Peyrard S; Klein C; Agueznay Nel H; Mosseri V; Laccourreye O; Bruneval P; Fridman WH; Brasnu DF; Tartour E Clin Cancer Res; 2006 Jan; 12(2):465-72. PubMed ID: 16428488 [TBL] [Abstract][Full Text] [Related]
14. Dysfunction of CD4+CD25high T regulatory cells in patients with recurrent aphthous stomatitis. Lewkowicz N; Lewkowicz P; Dzitko K; Kur B; Tarkowski M; Kurnatowska A; Tchórzewski H J Oral Pathol Med; 2008 Sep; 37(8):454-61. PubMed ID: 18318707 [TBL] [Abstract][Full Text] [Related]
15. Phenotyping of lymphocytes expressing regulatory and effector markers in infiltrating ductal carcinoma of the breast. Leong PP; Mohammad R; Ibrahim N; Ithnin H; Abdullah M; Davis WC; Seow HF Immunol Lett; 2006 Feb; 102(2):229-36. PubMed ID: 16246429 [TBL] [Abstract][Full Text] [Related]
16. Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients. Petersen RP; Campa MJ; Sperlazza J; Conlon D; Joshi MB; Harpole DH; Patz EF Cancer; 2006 Dec; 107(12):2866-72. PubMed ID: 17099880 [TBL] [Abstract][Full Text] [Related]
17. Differential changes in CD4+ and CD8+ effector and regulatory T lymphocyte subsets in the testis of rats undergoing autoimmune orchitis. Jacobo P; Guazzone VA; Jarazo-Dietrich S; Theas MS; Lustig L J Reprod Immunol; 2009 Jul; 81(1):44-54. PubMed ID: 19520436 [TBL] [Abstract][Full Text] [Related]
18. Unique phenotype of human tonsillar and in vitro-induced FOXP3+CD8+ T cells. Siegmund K; Rückert B; Ouaked N; Bürgler S; Speiser A; Akdis CA; Schmidt-Weber CB J Immunol; 2009 Feb; 182(4):2124-30. PubMed ID: 19201865 [TBL] [Abstract][Full Text] [Related]